Charles River Laboratories International (CRL) News Today $187.74 -9.16 (-4.65%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Mizuho Securities USA LLCMizuho Securities USA LLC lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2,336.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 96,871 shares of theNovember 16 at 9:39 AM | marketbeat.comCharles River Laboratories International Q3 Earnings TranscriptNovember 16 at 7:25 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by KBC Group NVKBC Group NV cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 37.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,566 shares of the medical research coNovember 16 at 5:53 AM | marketbeat.comVictory Capital Management Inc. Sells 117,418 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Victory Capital Management Inc. decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 25.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 348,276 shares of the medical research company's stock aNovember 15 at 4:59 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Entropy Technologies LPEntropy Technologies LP decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 51.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,125 shares ofNovember 14 at 4:46 AM | marketbeat.comEntropy Technologies LP Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Entropy Technologies LP lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 51.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,125 shareNovember 14 at 4:46 AM | marketbeat.comEmpower Advisory Group LLC Sells 3,497 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Empower Advisory Group LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 269,104 shares of the medical research company's stock after selling 3,November 13, 2024 | marketbeat.comInsider Selling: Charles River Laboratories International, Inc. (NYSE:CRL) Director Sells 6,621 Shares of StockNovember 13, 2024 | insidertrades.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by WCM Investment Management LLCWCM Investment Management LLC grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 33.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,367 shares of the medical research company's sNovember 12, 2024 | marketbeat.comAmalgamated Bank Trims Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Amalgamated Bank decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,121 shares of the medical reseaNovember 12, 2024 | marketbeat.comWilliam Blair Has Pessimistic Outlook of CRL Q4 EarningsNovember 12, 2024 | americanbankingnews.comCharles River price target raised to $227 from $203 at TD CowenNovember 11, 2024 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Price Target Raised to $227.00TD Cowen increased their price target on Charles River Laboratories International from $203.00 to $227.00 and gave the stock a "hold" rating in a research note on Monday.November 11, 2024 | marketbeat.comCharles River Laboratories to Present at UBS and Jefferies ConferencesNovember 11, 2024 | finance.yahoo.comCautious Optimism: Hold Rating for Charles River Labs Amid Mixed Signals and Market UncertaintiesNovember 11, 2024 | markets.businessinsider.comWilliam Blair Analysts Reduce Earnings Estimates for CRLCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - William Blair decreased their Q4 2024 earnings estimates for Charles River Laboratories International in a report issued on Thursday, November 7th. William Blair analyst M. Smock now anticipates that the medical research coNovember 11, 2024 | marketbeat.comJensen Investment Management Inc. Sells 3,730 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jensen Investment Management Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,180 shares of the medical research company's stockNovember 10, 2024 | marketbeat.comHold Rating for Charles River Labs Amid Mixed Performance and Market UncertaintiesNovember 8, 2024 | markets.businessinsider.comJ.P. Morgan Sticks to Its Hold Rating for Charles River Labs (CRL)November 8, 2024 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Upgraded to Hold at CLSACLSA raised Charles River Laboratories International from an "underperform" rating to a "hold" rating and set a $205.00 price target for the company in a report on Thursday.November 7, 2024 | marketbeat.comEvercore ISI Forecasts Strong Price Appreciation for Charles River Laboratories International (NYSE:CRL) StockEvercore ISI lifted their price target on Charles River Laboratories International from $190.00 to $225.00 and gave the company an "in-line" rating in a research note on Thursday.November 7, 2024 | marketbeat.comVan ECK Associates Corp Sells 6,633 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Van ECK Associates Corp decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,273 sharNovember 7, 2024 | marketbeat.comCharles River upgraded to Hold from Underperform at CLSANovember 6, 2024 | markets.businessinsider.comCharles River Laboratories International, Inc. (CRL) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comCharles River Laboratories Announces Third-Quarter 2024 ResultsNovember 6, 2024 | finanznachrichten.deCharles River Labs cuts 1,300 workers; will close more than a dozen sitesNovember 6, 2024 | bizjournals.comCharles River Laboratories Updates 2024 Guidance - UpdateNovember 6, 2024 | markets.businessinsider.comCharles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's WhyNovember 6, 2024 | msn.comCharles River Laboratories raises annual profit forecast on stabilizing biotech demandNovember 6, 2024 | reuters.comCharles River Laboratories International (NYSE:CRL) Issues FY 2024 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY 2024 earnings guidance. The company provided EPS guidance of 10.100-10.300 for the period, compared to the consensus estimate of 10.000. The company also issued revenue guidance of $4.0 billionillion-$4.0 billionillion, compared to the consensus estimate of $4.0 billionillion.November 6, 2024 | marketbeat.comCharles River Laboratories International Inc. Q3 Profit Decreases, But Beats EstimatesNovember 6, 2024 | markets.businessinsider.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by US Bancorp DEUS Bancorp DE lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 13,726 shares of the medical research company's stock after selling 7,851 shares duriNovember 6, 2024 | marketbeat.comStephens Inc. AR Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Stephens Inc. AR increased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 126.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,463 shares of the medical research company's stock after acquiring an adNovember 5, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stake Decreased by New York State Common Retirement FundNew York State Common Retirement Fund lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 119,725 shares of the medical resNovember 4, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Short Interest Up 7.1% in OctoberCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 2,110,000 shares, an increase of 7.1% from the September 30th total of 1,970,000 shares. Based on an average daily volume of 744,300 shares, the days-to-cover ratio is presently 2.8 days.November 1, 2024 | marketbeat.comCongress Asset Management Co. Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Congress Asset Management Co. trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 433October 31, 2024 | marketbeat.comWhat is Zacks Research's Forecast for CRL FY2024 Earnings?Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Analysts at Zacks Research reduced their FY2024 earnings per share (EPS) estimates for Charles River Laboratories International in a report released on Tuesday, October 29th. Zacks Research analyst R. Department now forecasOctober 31, 2024 | marketbeat.comWD Rutherford LLC Trims Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)WD Rutherford LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 87.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,714 shares of the mOctober 30, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Reduce" by AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have earned a consensus recommendation of "Reduce" from the fifteen analysts that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, teOctober 30, 2024 | marketbeat.comCharles River shipments of research monkeys spark investigation, STAT saysOctober 30, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Has $9.66 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Assenagon Asset Management S.A. raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 152.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 49,030 shares of theOctober 28, 2024 | marketbeat.comBoston Trust Walden Corp Sells 4,169 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Boston Trust Walden Corp trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 196,145 shares of the medical researOctober 27, 2024 | marketbeat.comDumont & Blake Investment Advisors LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)Dumont & Blake Investment Advisors LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 50.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,360 shares of the medicaOctober 25, 2024 | marketbeat.comCLSA Initiates Coverage of Charles River Laboratories International (CRL) with Underperform RecommendationOctober 24, 2024 | msn.comCLSA Begins Coverage on Charles River Laboratories International (NYSE:CRL)CLSA initiated coverage on shares of Charles River Laboratories International in a research report on Wednesday. They issued an "underperform" rating and a $167.00 price target for the company.October 23, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Trading Down 4.9% - Should You Sell?Charles River Laboratories International (NYSE:CRL) Stock Price Down 4.9% - Here's WhyOctober 22, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Acquires 509,163 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Allspring Global Investments Holdings LLC boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 40.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owneOctober 20, 2024 | marketbeat.comProfessional Advisory Services Inc. Grows Position in Charles River Laboratories International, Inc. (NYSE:CRL)Professional Advisory Services Inc. raised its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 73,040 shares of the medical research company's stockOctober 18, 2024 | marketbeat.comResearch Analysts Set Expectations for CRL Q3 EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities researchers at Zacks Research lowered their Q3 2024 earnings estimates for shares of Charles River Laboratories International in a report issued on Thursday, October 17th. Zacks Research analyst R. Department now aOctober 18, 2024 | marketbeat.comCharles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference CallOctober 16, 2024 | finance.yahoo.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.590.55▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼237▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Illumina News Waters News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
